Yüklüyor......
Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
PURPOSE: Combination of biological therapy and chemotherapy improves the survival of patients with metastatic colorectal cancer (mCRC). However, the optimal biological therapy sequence remains unclear. In this retrospective study, we evaluated the clinical outcomes of patients with mCRC treated with...
Kaydedildi:
| Yayımlandı: | Cancer Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6601597/ https://ncbi.nlm.nih.gov/pubmed/31090176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2235 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|